SEC Filing Details

SEC Filing Details

Document Details

Form
8-A12B
Filing Date
Nov 8, 2007
Document Date
Nov 8, 2007
Form Description
Registration of certain classes of securities 12(b) of the Securities Exchange Act
Filing Group
Registration Statements
Company
ReShape Lifesciences
Issuer
For investor inquiries, please contact:

ReShape Lifesciences Investor Contact:
Thomas Stankovich
Chief Financial Officer
949-276-6042
ir@ReShapeLifesci.com

Investor Contacts:
Rx Communications Group
Michael Miller
917-633-6086
mmiller@rxir.com

PRINT PAGE

EMAIL PAGE